News

3 in 10 Taiwanese Gen Z investors now include insurance in their portfolios

Younger investors aim to manage risk whilst building long-term wealth.

Slow progress reported on national renewable targets

Only 7 countries outside EU have updated RE targets since COP28 tripling pledge.

Surgical sutures market to be valued at $6.65b by 2030

Thanks to a rise in surgical interventions driven by an ageing population.

South Korea’s nuclear generation to reach 222.7TWh by 2035

The country has four upcoming reactors on top of 25 existing ones.

7MM hidradenitis suppurativa market to quadruple by 2034

Thanks to the approval and uptake of next-generation biologics.

What may hold back green bonds’ growth in India?

Various factors are seen to pose hurdles to the growth of green bonds critical for clean projects.

No major shift seen for global coal demand in 2025-2026

In China, coal demand is seen to slightly decline this year.

Biologic therapeutic market to hit $794.5b by 2029

Thanks to the demand for monoclonal antibodies, gene and cell therapies, and vaccines.

Hong Kong insurance premiums hit $28.6b in Q1 2025

This was driven by robust growth in both long-term and general insurance business.

Insurers broaden AI use beyond underwriting in Q3 2025

The industry saw higher AI adoption rates in customer service.

Onshore wind remains cheapest energy source in 2024

The addition of over 500 GW of RE prevented the use of fossil fuels worth $57b.

China leads in clinical trials outside North America and Europe in Q2

Meanwhile, India overtook Iran to claim second place.

South Korea immunochemistry analyser market to grow 4% annually until 2036

One key driver is the shift toward high-precision diagnostic systems.

Only 4% of insurers fully trust AI agents despite growing interest

42% of insurers have yet to develop a formal strategy for deploying AI agents.